Biphasic effect of diabetes on neuronal nitric oxide release in rat mesenteric arteries

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Sastre, Esther ^a,b   Caracuel, Laura ^a,b   Blanco Rivero, Javier ^a,b   Callejo, María ^a   Xavier, Fabiano E ^c   Balfagón, Gloria ^a,b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^c FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; ARGINASE 1; ARGINASE 2; ARGININE; COPPER ZINC SUPEROXIDE DISMUTASE; N(G) NITROARGININE METHYL ESTER; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PEROXYNITRITE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TETRAHYDROBIOPTERIN; UNCLASSIFIED DRUG; PEROXYNITROUS ACID; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; MALE; MESENTERIC ARTERY; NONHUMAN; OXIDATION REDUCTION STATE; PROTEIN EXPRESSION; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANIMAL; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; TIME FACTOR; VASOCONSTRICTION;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; ELECTRIC STIMULATION; MALE; MESENTERIC ARTERIES; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PEROXYNITROUS ACID; RATS; STREPTOZOCIN; SUPEROXIDE DISMUTASE; SUPEROXIDES; TIME FACTORS; VASOCONSTRICTION;

EID: 84974808134     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0156793     Document Type: Article

References (42)

1. Leon B.M., Maddox T.M. (2015). Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes 6:1246-1258. doi: 10.4239/wjd.v6.i13.1246 PMID: 26468341
2. Krentz A.J., Clough G., Byrne C.D. (2007). Interactions between microvascular and macrovascular disease in diabetes: pathophysiology and therapeutic implications. Diabetes Obes Metab. 9:781-791. PMID: 17924862
3. Paneni F., Beckman J.A., Creager M.A., Cosentino F. (2013). Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J. 34:2436-2443. doi: 10.1093/eurheartj/eht149 PMID: 23641007
4. Chatterjee A., Black S.M., Catravas J.D. (2008). Endothelial nitric oxide (NO) and its pathophysiologic regulation. Vascul Pharmacol. 49:134-140. doi: 10.1016/j.vph.2008.06.008 PMID: 18692595
5. Melikian N., Seddon M.D., Casadei B., Chowienczyk P.J., Shah A.M. (2009). Neuronal nitric oxide synthase and human vascular regulation. Trends Cardiovasc Med. 19:256-262. doi: 10.1016/j.tcm.2010.02.007 PMID: 20447567
6. Rochette L., Lorin J., Zeller M., Guilland J.C., Lorgis L., Cottin Y. et al (2013). Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets? Pharmacol Ther. 140:239-257. doi: 10.1016/j.pharmthera.2013.07.004 PMID: 23859953
7. Pieper GM (1999). Enhanced, unaltered and impaired nitric oxide-mediated endothelium-dependent relaxation in experimental diabetes mellitus: importance of disease duration. Diabetologia 42:204-213. PMID: 10064101
8. Cellek S., Foxwell N.A., Moncada S. (2003). Two phases of nitrergic neuropathy in streptozotocin-induced diabetic rats. Diabetes. 522353-2362.
9. Xavier F.E., Davel A.P., Rossoni L.V., Vassallo D.V. (2003). Time-dependent hyperreactivity to phenylephrine in aorta from untreated diabetic rats: role of prostanoids and calcium mobilization. Vascul Pharmacol. 40:67-76. PMID: 12646412
10. Xavier F.E., Salaices M., Márquez-Rodas I., Alonso M.J., Rossoni L.V., Vassallo D.V., et al. (2004). Neurogenic nitric oxide release increases in mesenteric arteries from ouabain hypertensive rats. J Hypertens. 22:949-957. PMID: 15097235
11. Ferrer M., Sánchez M., Minoves N., Salaices M., Balfagón G. (2003) Aging increases neuronal nitric oxide release and superoxide anion generation in mesenteric arteries from spontaneously hypertensive rats. J Vasc Res. 40:509-519. PMID: 14646371
12. Arrick D.M., Sharpe G.M., Sun H., Mayhan W.G. (2007). nNOS-dependent reactivity of cerebral arterioles in Type 1 diabetes. Brain Res. 1184:365-371. PMID: 17991456
13. Gangula P.R., Mukhopadhyay S., Ravella K., Cai S., Channon K.M., Garfield R.E., et al. (2010). Tetrahydrobiopterin (BH4), a cofactor for nNOS, restores gastric emptying and nNOS expression in female diabetic rats. Am J Physiol Gastrointest Liver Physiol. 298:692-699.
14. Sánchez A., Contreras C., Martínez M.P., Climent B., Benedito S., García-Sacristán A., et al. (2012). Role of neural NO synthase (nNOS) uncoupling in the dysfunctional nitrergic vasorelaxation of penile arteries from insulin-resistant obese Zucker rats. PLoS One. 4:e3602
15. Al-Noah Z., McKenna D., Langdale C., Thor K.B., Marson L., Burgard E., et al. (2014). Nitrergic relaxations and phenylephrine contractions are not compromised in isolated urethra in a rat model of diabetes. Auton Neurosci. 183:58-65. doi: 10.1016/j.autneu.2014.03.002 PMID: 24656892
16. Andrew P.J., Mayer B. (1999). Enzymatic function of nitric oxide synthases. Cardiovasc Res. 43:521-531. PMID: 10690324
17. Ryoo S., Lemmon C.A., Soucy K.G., Gupta G., White A.R., Nyhan D., et al (2006). Oxidized low-density lipoprotein-dependent endothelial arginase II activation contributes to impaired nitric oxide signaling. Circ Res. 99:951-960. PMID: 17008605
18. Pernow J., Jung C. (2015). The Emerging Role of Arginase in Endothelial Dysfunction in Diabetes. Curr Vasc Pharmacol. Dec 2. [Epub ahead of print].
19. Nielsen K.C., Owman C. (1971). Contractile response and amine receptor mechanism in isolated middle cerebral artery of the cat. Brain Res. 27:33-42. PMID: 4396591
20. Marín J., Balfagón G. (1998). Effect of clenbuterol on non-endothelial nitric oxide release in rat mesenteric arteries and the involvement of beta-adrenoceptors. Br J Pharmacol. 124:473-478. PMID: 9647470
21. Blanco-Rivero J., de las Heras N., Martín-Fernández B., Cachofeiro V., Lahera V., Balfagón G. (2011). Rosuvastatin restored adrenergic and nitrergic function in mesenteric arteries from obese rats. Br J Pharmacol. 162:271-285. doi: 10.1111/j.1476-5381.2010.01030.x PMID: 20840472
22. Blanco-Rivero J., Furieri L.B., Vassallo D.V., Salaices M., Balfagón G. (2011). Chronic HgCl(2) treatment increases vasoconstriction induced by electrical field stimulation: role of adrenergic and nitrergic innervation. Clin Sci (Lond). 121:331-341.
23. Sastre E., Blanco-Rivero J., Caracuel L., Lahera V., Balfagón G. (2012). Effects of lipopolysaccharide on the neuronal control of mesenteric vascular tone in rats: mechanisms involved. Shock. 38:328-334. doi: 10.1097/SHK.0b013e31826240ba PMID: 22744306
24. de Queiroz D.B., Sastre E., Caracuel L., Callejo M., Xavier F.E., Blanco-Rivero J., et al. (2015). Alterations in perivascular innervation function in mesenteric arteries from offspring of diabetic rats. Br J Pharmacol. 172:4699-4713. doi: 10.1111/bph.13244 PMID: 26177571
25. Capellini V.K., Celotto A.C., Baldo C.F., Olivon V.C., Viaro F., Rodrigues A.J., et al. (2010). Diabetes and vascular disease: basic concepts of nitric oxide physiology, endothelial dysfunction, oxidative stress and therapeutic possibilities. Curr Vasc Pharmacol. 8:526-544. PMID: 19485895
26. de las Heras N, Valero-Muñoz M, Ballesteros S, Gómez-Hernández A, Martín-Fernández B, Blanco-Rivero J, et al. (2013) Factors involved in rosuvastatin induction of insulin sensitization in rats fed a high fat diet. Nutr Metab Cardiovasc Dis.; 23(11): 1107-14. doi: 10.1016/j.numecd.2012.11.009 PMID: 23434394
27. Hoang H.H., Padgham S.V., Meininger C.J. (2013). L-arginine, tetrahydrobiopterin, nitric oxide and diabetes. Curr Opin Clin Nutr Metab Care. 16:76-82. doi: 10.1097/MCO.0b013e32835ad1ef PMID: 23164986
28. Bendall J.K., Douglas G., McNeill E., Channon K.M., Crabtree M.J. (2014). Tetrahydrobiopterin in cardiovascular health and disease. Antioxid Redox Signal. 20:3040-3077. doi: 10.1089/ars.2013.5566 PMID: 24294830
29. Crabtree M.J., Smith C.L., Lam G., Goligorsky M.S., Gross S.S. (2008). Ratio of 5,6,7,8-tetrahydrobiopterin to 7,8-dihydrobiopterin in endothelial cells determines glucose-elicited changes in NO vs. superoxide production by eNOS. Am J Physiol Heart Circ Physiol. 294:1530-1540.
30. Durlu N.T., Ismailoglu U.B., Sahin-Erdemli I. (2003). Inhibition of L-arginine transport by reactive oxygen species in rat anococcygeus muscle. Fundam Clin Pharmacol. 17:609-614. PMID: 14703722
31. Jin L., Caldwell R.B., Li-Masters T., Caldwell R.W. (2007). Homocysteine induces endothelial dysfunction via inhibition of arginine transport. J Physiol Pharmacol. 58:191-206. PMID: 17622691
32. Pieper G.M., Dondlinger L.A. (1997). Plasma and vascular tissue arginine are decreased in diabetes: acute arginine supplementation restores endothelium-dependent relaxation by augmenting cGMP production. J Pharmacol Exp Ther. 283:684-691 PMID: 9353386
33. Durante W., Johnson F.K., Johnson R.A. (2007). Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clin Exp Pharmacol Physiol. 34:906-911. PMID: 17645639
34. Bagi Z., Feher A., Dou H., Broskova Z. (2013). Selective up-regulation of arginase-1 in coronary arteries of diabetic patients. Front Immunol. 4:293. doi: 10.3389/fimmu.2013.00293 PMID: 24133491
35. Pernow J., Kiss A., Tratsiakovich Y., Climent B. (2015) Tissue-specific up-regulation of arginase I and II induced by p38 MAPK mediates endothelial dysfunction in type 1 diabetes mellitus. Br J Pharmacol. 172:4684-4698. doi: 10.1111/bph.13242 PMID: 26140333
36. Toque H.A., Nunes K.P., Yao L., Liao J.K., Webb R.C., Caldwell R.B., et al. (2013). Activated Rho kinase mediates diabetes-induced elevation of vascular arginase activation and contributes to impaired corpora cavernosa relaxation: possible involvement of p38 MAPK activation. J Sex Med. 10:1502-1515. doi: 10.1111/jsm.12134 PMID: 23566117
37. Adak S., Santolini J., Tikunova S., Wang Q., Johnson J.D., Stuehr D.J. (2001). Neuronal nitric-oxide synthase mutant (Ser-1412 → Asp) demonstrates surprising connections between heme reduction, NO complex formation, and catalysis. J Biol Chem. 276:1244-1252 PMID: 11038355
38. Rameau G.A., Chiu L.Y., Ziff E.B. (2004). Bidirectional regulation of neuronal nitric-oxide synthase phosphorylation at serine 847 by the N-methyl-D-aspartate receptor. J Biol Chem. 279:14307-14314. PMID: 14722119
39. Kasamatsu S., Watanabe Y., Sawa T., Akaike T., Ihara H. (2014). Redox signal regulation via nNOS phosphorylation at Ser847 in PC12 cells and rat cerebellar granule neurons. Biochem J. 459:251-263. doi: 10.1042/BJ20131262 PMID: 24499461
40. Ferrer M., Marín J., Balfagón G. (2000). Diabetes alters neuronal nitric oxide release from rat mesenteric arteries. Role of protein kinase C. Life Sci. 66:337-345. PMID: 10665985
41. Heine C.L., Kolesnik B., Schmidt R., Werner E.R., Mayer B., Gorren A.C. (2014). Interaction between neuronal nitric-oxide synthase and tetrahydrobiopterin revisited: studies on the nature and mechanism of tight pterin binding. Biochemistry. 53:1284-1295. doi: 10.1021/bi401307r PMID: 24512289
42. Cellek S., Anderson P.N., Foxwell N.A. (2005). Nitrergic neurodegeneration in cerebral arteries of streptozotocin-induced diabetic rats: a new insight into diabetic stroke. Diabetes 54:212-219. PMID: 15616031